Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ji-Fa Fan"'
Autor:
Wen-Ling Dai, Yi-Ni Bao, Ji-Fa Fan, Bin Ma, Shan-Shan Li, Wan-Li Zhao, Bo-Yang Yu, Ji-Hua Liu
Publikováno v:
Journal of Advanced Research, Vol 28, Iss , Pp 139-148 (2021)
Introduction: Spinal N-methyl-D-aspartate receptor (NMDAR) is vital in chronic pain, while NMDAR antagonists have severe side effects. NMDAR has been reported to be controlled by G protein coupled receptors (GPCRs), which might present new therapeuti
Externí odkaz:
https://doaj.org/article/c0ac096b476046a196d81f11b30cec65
Publikováno v:
Cell Communication and Signaling, Vol 18, Iss 1, Pp 1-13 (2020)
Abstract Background Anti-nerve growth factor (NGF) monoclonal antibodies (anti-NGF mAbs) have been reported to significantly attenuate pain, but the mechanism involved has not been fully elucidated, and the serious adverse events associated with mAbs
Externí odkaz:
https://doaj.org/article/474cac35dfa047c4a3936fc6cbc18141
Publikováno v:
Experimental & Molecular Medicine
Dopamine D1 receptor (D1DR) and D2 receptor (D2DR) are closely associated with pain modulation, but their exact effects on neuropathic pain and the underlying mechanisms remain to be identified. Our research revealed that intrathecal administration o
Publikováno v:
Journal of Advanced Research
Journal of Advanced Research, Vol 28, Iss, Pp 139-148 (2021)
Journal of Advanced Research, Vol 28, Iss, Pp 139-148 (2021)
Graphical abstract
Introduction Spinal N-methyl-D-aspartate receptor (NMDAR) is vital in chronic pain, while NMDAR antagonists have severe side effects. NMDAR has been reported to be controlled by G protein coupled receptors (GPCRs), which might
Introduction Spinal N-methyl-D-aspartate receptor (NMDAR) is vital in chronic pain, while NMDAR antagonists have severe side effects. NMDAR has been reported to be controlled by G protein coupled receptors (GPCRs), which might
Publikováno v:
Regional Anesthesia & Pain Medicine. 45:219-229
Background and objectivesNeuropathic pain is partially refractory to currently available treatments. Although some studies have reported that apoptosis signal-regulating kinase 1 (ASK1) may inhibit chronic pain, the mechanisms underlying this process
Additional file 1. Supplementary material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f951f532592fdb79da20e92f389a01e
Publikováno v:
Regional anesthesia and pain medicine. 45(3)
Neuropathic pain is partially refractory to currently available treatments. Although some studies have reported that apoptosis signal-regulating kinase 1 (ASK1) may inhibit chronic pain, the mechanisms underlying this process have not been fully eluc
Autor:
Wen-Ling Dai, Yi-Ni Bao, Ji-Fa Fan, Shan-Shan Li, Wan-Li Zhao, Bo-Yang Yu, Ji-Hua Liu, Dai, Wen-Ling, Bao, Yi-Ni, Fan, Ji-Fa, Li, Shan-Shan, Zhao, Wan-Li, Yu, Bo-Yang, Liu, Ji-Hua
Publikováno v:
Regional Anesthesia & Pain Medicine; Mar2020, Vol. 45 Issue 3, p219-229, 11p